• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于社区健康计划的重度溃疡性结肠炎自然史

Natural history of severe ulcerative colitis in a community-based health plan.

作者信息

Allison James, Herrinton Lisa J, Liu Liyan, Yu Jenny, Lowder James

机构信息

Division of Research, Kaiser Permanente Northern California, Oakland, California 94612, USA.

出版信息

Clin Gastroenterol Hepatol. 2008 Sep;6(9):999-1003. doi: 10.1016/j.cgh.2008.05.022.

DOI:10.1016/j.cgh.2008.05.022
PMID:18774533
Abstract

BACKGROUND & AIMS: We sought to evaluate long-term outcomes of patients with severe ulcerative colitis (UC) after their first hospitalization for the disease.

METHODS

A cohort of 656 patients hospitalized for UC during 1996 to 2004 was followed up for 9 years through 2004. Time-to-event was estimated using actuarial methods, and the proportions of those under follow-up evaluation who experienced outcomes at month 3, year 1, and year 5 were determined. Outcome measures studied were time to subsequent colectomy, rehospitalization for inflammatory bowel disease, and restarting steroid medication. We also used survival analysis to evaluate whether patient characteristics predicted the risk of rehospitalization and colectomy.

RESULTS

Among 656 patients initially hospitalized for severe UC, 20% (N = 129) underwent colectomy during their initial hospitalization. Of the remaining 527, a total of 95% (N = 498) were discharged on a steroid taper. At 1 year after discharge, 29% of those remaining under observation were rehospitalized for UC, and an additional 10% required colectomy. At 1 and 5 years after discharge, 34% and 26% received at least a 90-day supply of steroid in the preceding 9 months. Risk of rehospitalization and colectomy were unrelated to the patient's age, sex, or race/ethnicity.

CONCLUSIONS

The risk for colectomy in patients hospitalized for the first time with severe UC is 20%. In the 3 months after hospitalization the risk for colectomy is 6%. After that, risks appear to decrease proportionate to the time since initial hospitalization.

摘要

背景与目的

我们旨在评估重度溃疡性结肠炎(UC)患者首次因该病住院后的长期预后。

方法

对1996年至2004年期间因UC住院的656例患者进行了为期9年的随访,直至2004年。采用精算方法估计事件发生时间,并确定在随访评估中在第3个月、第1年和第5年出现预后情况的患者比例。所研究的预后指标包括至后续结肠切除术的时间、因炎症性肠病再次住院以及重新开始使用类固醇药物。我们还使用生存分析来评估患者特征是否可预测再次住院和结肠切除术的风险。

结果

在最初因重度UC住院的656例患者中,20%(n = 129)在初次住院期间接受了结肠切除术。在其余527例患者中,共有95%(n = 498)在逐渐减少类固醇用量的情况下出院。出院后1年,仍在观察的患者中有29%因UC再次住院,另有10%需要进行结肠切除术。出院后1年和5年,分别有34%和26%的患者在之前9个月内至少接受了90天的类固醇药物治疗。再次住院和结肠切除术的风险与患者的年龄、性别或种族/民族无关。

结论

首次因重度UC住院的患者进行结肠切除术的风险为20%。住院后3个月内进行结肠切除术的风险为6%。此后,风险似乎与初次住院后的时间成比例下降。

相似文献

1
Natural history of severe ulcerative colitis in a community-based health plan.基于社区健康计划的重度溃疡性结肠炎自然史
Clin Gastroenterol Hepatol. 2008 Sep;6(9):999-1003. doi: 10.1016/j.cgh.2008.05.022.
2
Response to first intravenous steroid therapy determines the subsequent risk of colectomy in ulcerative colitis patients.对于溃疡性结肠炎患者,首次静脉用类固醇治疗的反应决定了随后结肠切除术的风险。
J Gastrointestin Liver Dis. 2011 Dec;20(4):359-63.
3
Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study).溃疡性结肠炎最初10年的临床病程:基于人群的发病队列研究结果(IBSEN研究)
Scand J Gastroenterol. 2009;44(4):431-40. doi: 10.1080/00365520802600961.
4
Intravenous cyclosporin in ulcerative colitis: a five-year experience.溃疡性结肠炎的静脉注射环孢素:五年经验
Am J Gastroenterol. 1999 Jun;94(6):1587-92. doi: 10.1111/j.1572-0241.1999.01149.x.
5
Colectomy rate in acute severe ulcerative colitis in the infliximab era.英夫利昔单抗时代急性重症溃疡性结肠炎的结肠切除术发生率。
Dig Liver Dis. 2008 Oct;40(10):821-6. doi: 10.1016/j.dld.2008.03.014. Epub 2008 May 9.
6
Incidence of colectomy during long-term follow-up after cyclosporine-induced remission of severe ulcerative colitis.环孢素诱导重症溃疡性结肠炎缓解后的长期随访期间结肠切除术的发生率。
Clin Gastroenterol Hepatol. 2006 Jun;4(6):760-5. doi: 10.1016/j.cgh.2006.04.001. Epub 2006 May 22.
7
Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up.他克莫司对重度激素难治性或激素依赖性炎症性肠病患者安全有效——一项长期随访研究
Am J Gastroenterol. 2006 May;101(5):1048-56. doi: 10.1111/j.1572-0241.2006.00524.x.
8
The natural history of pediatric ulcerative colitis: a population-based cohort study.儿童溃疡性结肠炎的自然病史:一项基于人群的队列研究。
Am J Gastroenterol. 2009 Aug;104(8):2080-8. doi: 10.1038/ajg.2009.177. Epub 2009 May 12.
9
Long-term colectomy rate after intensive intravenous corticosteroid therapy for ulcerative colitis prior to the immunosuppressive treatment era.免疫抑制治疗时代之前,溃疡性结肠炎患者接受强化静脉注射皮质类固醇治疗后的长期结肠切除率。
Am J Gastroenterol. 2007 Nov;102(11):2513-9. doi: 10.1111/j.1572-0241.2007.01435.x. Epub 2006 Aug 4.
10
Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort.炎症性肠病的黏膜愈合:来自挪威一项基于人群队列研究的结果
Gastroenterology. 2007 Aug;133(2):412-22. doi: 10.1053/j.gastro.2007.05.051. Epub 2007 Jun 2.

引用本文的文献

1
Hyperbaric oxygen therapy for ulcerative colitis patients hospitalized for moderate to severe flares (HBOT-UC): study protocol for a multi-center, randomized, double-blind, sham-controlled trial.针对因中度至重度发作而住院的溃疡性结肠炎患者的高压氧疗法(HBOT-UC):一项多中心、随机、双盲、假对照试验的研究方案。
Trials. 2025 Jun 22;26(1):220. doi: 10.1186/s13063-025-08932-5.
2
Influence of biological sex in inflammatory bowel diseases.生物性别对炎症性肠病的影响。
Nat Rev Gastroenterol Hepatol. 2025 Feb 17. doi: 10.1038/s41575-025-01038-y.
3
Predictors for colectomy in patients with acute severe ulcerative colitis: a systematic review and meta-analysis.
预测急性重度溃疡性结肠炎患者行结肠切除术的因素:系统评价和荟萃分析。
BMJ Open Gastroenterol. 2024 Nov 14;11(1):e001587. doi: 10.1136/bmjgast-2024-001587.
4
Clinical Trial Design Considerations for Hospitalised Patients With Ulcerative Colitis Flares and Application to Study Hyperbaric Oxygen Therapy in the NIDDK HBOT-UC Consortium.溃疡性结肠炎住院患者发作的临床试验设计考虑因素及在 NIDDK HBOT-UC 联合体高压氧治疗研究中的应用。
Aliment Pharmacol Ther. 2024 Dec;60(11-12):1512-1524. doi: 10.1111/apt.18326. Epub 2024 Oct 15.
5
Biologic Therapies for the Treatment of Post-ileal Pouch Anal Anastomosis Surgery Chronic Inflammatory Disorders: Systematic Review and Meta-analysis.生物疗法治疗回肠储袋肛管吻合术慢性炎症性疾病:系统评价与荟萃分析
J Can Assoc Gastroenterol. 2022 Aug 15;5(6):287-296. doi: 10.1093/jcag/gwac026. eCollection 2022 Dec.
6
State-of-the-art surgery for ulcerative colitis.溃疡性结肠炎的先进手术治疗。
Langenbecks Arch Surg. 2021 Sep;406(6):1751-1761. doi: 10.1007/s00423-021-02295-6. Epub 2021 Aug 28.
7
Dental pulp stem cells overexpressing hepatocyte growth factor facilitate the repair of DSS-induced ulcerative colitis.过表达肝细胞生长因子的牙髓干细胞促进葡聚糖硫酸钠诱导的溃疡性结肠炎的修复。
Stem Cell Res Ther. 2021 Jan 7;12(1):30. doi: 10.1186/s13287-020-02098-4.
8
Long-term outcomes of acute severe ulcerative colitis in the rescue therapy era: A multicentre cohort study.急性重症溃疡性结肠炎在挽救治疗时代的长期结局:一项多中心队列研究。
United European Gastroenterol J. 2021 May;9(4):507-516. doi: 10.1177/2050640620977405. Epub 2021 Feb 16.
9
A Microsimulation Model to Project the 5-Year Impact of Using Hyperbaric Oxygen Therapy for Ulcerative Colitis Patients Hospitalized for Acute Flares.一种用于预测接受高压氧治疗的溃疡性结肠炎患者在急性发作期住院 5 年影响的微观模拟模型。
Dig Dis Sci. 2021 Nov;66(11):3740-3752. doi: 10.1007/s10620-020-06707-3. Epub 2020 Nov 13.
10
Colorectal dysplasia and adenocarcinoma in patients with ulcerative colitis: an experience from a tertiary care hospital.溃疡性结肠炎患者的结直肠异型增生和腺癌:来自一家三级护理医院的经验。
World J Surg Oncol. 2018 Apr 19;16(1):81. doi: 10.1186/s12957-018-1385-7.